While there have been reports from drugmakers about possible interruptions with FDA matters due to staff layoffs, one company ...

Analysis found 25% tariff on pharmaceutical imports would hike U.S. drug costs by nearly $51 billion annually, boosting ...

Many doctors recommend routine follow-up tests for cancer patients after they’ve completed a course of treatment, with the ...

Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...

A closely watched clinical trial testing what could be the world’s first new tuberculosis vaccine in a century has hit its ...

A close look at Chris Klomp's path to the top of Medicare, which pays for the health care of 68 million Americans.

Confounded by a confusing expression or dream from a patient, I might seemingly shift gears and ask myself, 'What if this ...

Device companies already enjoy big profit margins and are finding ways to avoid the impact of President Trump's tariffs.

As Congress returns to work, STAT is tracking what health spending will get cut and when RFK Jr. will testify.

While physician-scientists are supported in splitting their time between research and clinical work, nurse-scientists are not ...

After months of discussion, Germany’s Merck KGaA said Monday it would buy SpringWorks Therapeutics for $47 a share in cash, a ...

We are navigating political interference, institutional instability, and growing uncertainty across the cancer research ...